New oral antiviral drug to be used for treatment of COVID-19
By Zhang Zhihao |
chinadaily.com.cn |
Updated: 2023-03-23 19:18
Share
Share - WeChat
The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Tech innovation propels nation's industrial future
- China launches low Earth orbit satellite group
- China successfully launches new test satellite
- Books of Xi's discourses on adhering to deepening reform comprehensively published
- China activates Level-IV emergency flood-control response in Hainan
- Flash flood leaves eight campers dead and four missing
